IgA deficiency, epilepsy, and phenytoin treatment

Lancet. 1975 Oct 4;2(7936):632-5. doi: 10.1016/s0140-6736(75)90115-4.

Abstract

In a prospective study of thirty-two children with seizures treated with phenytoin (diphenylhydantoin), five had low levels of serum-IgA before treatment. All of these were among the fifteen who had had febrile convulsions in infancy. IgA levels fell significantly during 6 months treatment in the fourteen patients studied sequentially. Treated children with low serum-IgA had normal numbers of lymphocytes with surface IgA. This suggests that phenytoin causes failure of terminal differentiation of B lymphocytes, and is the first known cause of this, the commonest mechanism of immunoglobulin deficiency.

MeSH terms

  • Adolescent
  • Cell Membrane / immunology
  • Child
  • Child, Preschool
  • Epilepsy / drug therapy
  • Epilepsy / immunology*
  • Female
  • Humans
  • IgA Deficiency*
  • Immunoglobulin A / metabolism
  • Immunoglobulin G / metabolism
  • Immunoglobulin M / metabolism
  • Immunologic Deficiency Syndromes / chemically induced
  • Infant
  • Male
  • Phenytoin / adverse effects*
  • Phenytoin / therapeutic use
  • Prospective Studies

Substances

  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Phenytoin